Latest "Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors" News Stories - Page: 3

14:31 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors" found in our extensive news archives from over 250 global news sources.

More Information about Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors for you to read. Along with our medical data and news we also list Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors Clinical Trials, which are updated daily. BioPortfolio also has a large database of Panobinostat And Epirubicin In Treating Patients With Metastatic Malignant Solid Tumors Companies for you to search.

Showing "Panobinostat Epirubicin Treating Patients With Metastatic Malignant Solid" News Articles 51–75 of 23,000+

Friday 22nd March 2019

Conatus’ Investigational Emricasan Fails to Meet Primary Endpoint in Phase 2b Trial in NASH Fibrosis

SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced top-line results from the company’s Phase 2b ENCORE-NF clinical trial in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and liver fibrosis. The trial’s primary endpoint was a ≥1 CRN fibrosis stage improvement with no worsening of steatohepatitis compared with plac...

7T MRI scans improve care for patients with focal epilepsy

Managing MS

FRIDAY, March 22, 2019 -- Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says. "Patients get a predisposed feeling that their life is doomed. That it's going to be a complicated life, which isn't...

CAD Patients With Cancer Diagnosis Face Significant Financial Burden

(MedPage Today) -- Researchers call for more interdisciplinary/integrated care of both conditions

USAWorldMeds Names Neurologist & Addiction Medicine Specialist Dr. Russell Surasky as Expert Speaker for New Ground-Breaking Medication Lucemyra

Lucemyra is the First FDA Approved Medicine to Treat Opioid Withdrawal Syndrome (OWS). GREAT NECK. N.Y. (PRWEB) March 22, 2019 “Not a day goes by when we don’t learn more about the devastation caused by opioid addiction. Every day in the United States approximately 4,000 individuals start using opiates for non-medical purposes. We are now up to about 130 opioid overdoses per day,” says Neur...

Sharp Transitions Named $100k Winner of 2019 Hearst Health Prize

Hearst Health, in partnership with the Jefferson College of Population Health has namedSharp Transitions as the winner of the 2019 Hearst Health Prize for its home-based palliative care program for patients with advanced and progressive chronic illness who are not ready for hospice care. The $100k annual award was given at the Population Health Colloquium ... Read More

Quality of palliative pain relief better with specialist nurses

Patients at home who are approaching the end-of-life experience substantially better pain relief if they receive specialist palliative care from a nurse, according to researchers.

Vitamin K to Reverse Excessive VKA Anticoagulation

Beyond holding anticoagulation, adding vitamin K did not reduce mortality, bleeding, or thrombosis risks in nonbleeding patients with elevated INRs.

Recent Developments in Hemophilia: Therapy With Emicizumab

(MedPage Today) -- Development finally provides hemophilia A patients with inhibitors as an attractive option to reduce the risk of bleeding

Researchers to test heart drug for COPD patients

University of Aberdeen researchers are set to test beta-blockers for COPD patients.

INFINITY: SBP Goal in High-Functioning Elderly Clear as WMH

The principal investigator discusses the effects of intensive vs standard systolic blood pressure on mobility, cognition, and cardiovascular outcomes in high-functioning elderly patients. on Medscape

Cancer Disease Label Affects Patient Decision-Making

(MedPage Today) -- Calling low-risk malignant neoplasms 'cancer' may lead to overtreatment, study suggests

Trueman Man Clinic Achieves 10000 Surgery Milestone with Its SWITCH Operation

Trueman Man Clinic Network announced that the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation), has been successfully completed. This press release features multimedia. View the full release here:

Viewpoints: Doctors Need To Stop Saying No To Patients Who Need Opioids; FDA’s E-Cigarette Policies Could Make It Tough On U.S. Troops

Opinion writers weigh in on these health topics and others.

‘A Huge Step Forward’: Research Breakthrough Sparks Hope For Preserving Fertility Of Young Boys With Cancer

"Fertility issues for kids with cancer were ignored" for years, said University of Pittsburgh reproductive scientist Kyle Orwig. "Many of us dream of growing up and having our own families. We hope our research will help these young patients to do that." Until now, boys hadn't had a realistic option to preserve their fertility, but that may be changing.

Biomarker for dcSSc Outcome ID'd (CME/CE)

(MedPage Today) -- Progressive skin fibrosis associated with lung deterioration, all-cause death in patients with diffuse cutaneous systemic sclerosis

Smiths Medical announces launch of Level 1 convective warmer

This next-generation high-flow convective warmer gives health care providers a quiet, simple and safe thermal care solution to help patients maintain normal body temperature through every stage of The post Smiths Medical announces launch of Level 1 convective warmer appeared first on Compelo Medical Devices - Latest industry news and analysis.

Genetesis CardioFlux™ Platform Receives FDA 510(k) Clearance

Next-generation magnetocardiography and cloud computing enable rapid, non-invasive cardiac imaging in the Emergency Department Genetesis, a medical technology company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has received FDA 510(k) clearance for its cardiac imaging platform. The platfor...

Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in Treating ADHD?

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common mental disorders with prevalence of 3%–7% among school-age children and its symptoms persist in 60% of adults. It is estimated that the prevalence of ADHD in adults is ∼4% (Castells et al. 2011). “ADHD has negative effects on children and their parent’s lives and also inflicts financial […] The post Could ...

Many Patients Still Employ Strategies to Reduce Prescription Drug Costs

FRIDAY, March 22, 2019 -- The number of adults reporting the use of strategies, such as requesting a lower-cost medication or not using medication as prescribed, to reduce prescription drug costs remained stable in 2015 to 2017, according to a March...

CancerIQ and AliveAndKickn Collaborate to Advance Lynch Syndrome Screening, Education and Research

Partnership to better help providers and patients take preventative measures against hereditary cancer CHICAGO (PRWEB) March 22, 2019 CancerIQ, a cancer risk assessment and management company, and AliveAndKickn, a Lynch Syndrome patient advocacy group, are partnering to help hospitals identify, educate and empower patients who have Lynch Syndrome. Together, they also aim to bolster enrollment in ...

Senseonics Launches the Eversense® Bridge Patient Access Program in the U.S.

Patients Can Access Long-term Eversense CGM for only $99* Under Program Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, has announced the launch of the Eversense Bridge Program. ...

Integrating Social and Medical Care: Making Matters Worse?

This commentary explores the potential consequences of bringing information about patients' social circumstances into health care delivery decisions. Annals of Family Medicine

Crohn's Disease Treatment Update

This article presents the American College of Gastroenterology's updated guidelines on managing Crohn's disease in adult patients. U.S. Pharmacist

Perioperative BP Monitoring in Patients With Obesity

What alternatives to traditional arm cuffs exist for noninvasive blood pressure measurement in patients with obesity? Anesthesia & Analgesia

Quick Search


News Quicklinks